Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates

Published:2022-04-10 Issue:5 Volume:12 Page:
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain and Behavior

Author:

Rekik Arwa¹^ORCID,Aissi Mona¹²,Rekik Islem³⁴,Mhiri Mariem¹²,Frih Mahbouba Ayed¹²

Affiliation:

1. Department of Neurology University Hospital Fattouma Bourguiba Monastir Monastir Tunisia

2. Faculty of Medicine of Monastir Fattouma Bourguiba Monastir Tunisia

3. BASIRA Lab Faculty of Computer and Informatics Istanbul Technical University Istanbul Turkey

4. School of Science and Engineering Computing University of Dundee Dundee UK

Publisher

Wiley

Subject

Behavioral Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2573

Reference54 articles.

1. Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls

2. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options

3. Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab

4. What (more) can verbal fluency tell us about multiple sclerosis?;Barois E.;Annals of Physical and Rehabilitation Medicine,2020

5. Adult neurogenesis in the dentate gyrus: General concepts and potential implications

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?;Brain Sciences;2023-12-23

2. Associations Between Cognitive Impairment and Neuroimaging in Patients with Multiple Sclerosis;Archives of Clinical Neuropsychology;2023-09-12

3. Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light;Multiple Sclerosis Journal;2023-08-02

4. PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS;World of Medicine and Biology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3